Article Details

Athira Pharma Presents Study Overview and Baseline Data from ACT-AD Phase 2 Trial of ...

Retrieved on: 2022-03-20 09:23:36

Tags for this article:

Click the tags to see associated articles and topics

Athira Pharma Presents Study Overview and Baseline Data from ACT-AD Phase 2 Trial of .... View article details on hiswai:

Excerpt

BOTHELL, Wash., March 20, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on ...

Article found on: www.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up